SCHEMBL5651552

SCHEMBL5651552

CC(C)N(C(=O)c1ccc(-c2ccccc2)cc1)[C@@H](CCC(=O)O)C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MMP12 P39900 2/20 0.45
HPGD P15428 4/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
LMNA P02545 2/20 0.43
FFAR1 O14842 1/20 0.43
CYP1A2 P05177 1/20 0.43
HIF1A Q16665 1/20 0.43
KDM4E B2RXH2 1/20 0.41
MCOLN3 Q8TDD5 1/20 0.41
ADAMTS4 O75173 2/20 0.40
MMP8 P22894 2/20 0.40
MMP13 P45452 2/20 0.40
MMP9 P14780 1/20 0.40
NPC1 O15118 2/20 0.40
ADAMTS5 Q9UNA0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4356535 0.80 MMP12 (0.43) TRPM8MMP12HPGDALDH1A1MAPT
SCHEMBL2247308 0.80 TRPM8 (0.43) TRPM8MMP12HPGDALDH1A1MAPT
SCHEMBL30268201 0.79 NPSR1 (0.66) NPSR1HPGDALDH1A1MAPTSMN1; SMN2
SCHEMBL4365442 0.78 MMP12 (0.42) MMP12HPGDALDH1A1MAPTRAB9A
SCHEMBL4364691 0.77 MMP12 (0.41) TRPM8NPSR1MMP12HPGDALDH1A1
SCHEMBL4357426 0.77 MMP12 (0.43) MMP12HPGDALDH1A1MAPTRAB9A
SCHEMBL5652194 0.77 MMP12 (0.41) TRPM8NPSR1MMP12HPGDALDH1A1
SCHEMBL4369489 0.76 PTGES (0.45) MMP12HPGDALDH1A1MAPTRAB9A
SCHEMBL5654170 0.76 MMP12 (0.41) TRPM8NPSR1MMP12HPGDALDH1A1
SCHEMBL2247828 0.76 MMP12 (0.42) MMP12HPGDALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043066-A1 Glutamate aggrecanase inhibitors WYETH (US) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043066-A1 Glutamate aggrecanase inhibitors ADAMTS5, ADAMTS1, ADAMTS7 TRPM8 1187/4885NPSR1 440/4885MMP12 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.